Solving the Hydroxychloroquine Dosing Dilemma With a Smartphone App
Open Access
- 1 February 2018
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 136 (2), 218-219
- https://doi.org/10.1001/jamaophthalmol.2017.6076
Abstract
Hydroxychloroquine retinopathy (HCR) is a potentially blinding disease. Once HCR is detected, there is no treatment and the disease often continues to progress, even when the medication is stopped. Hence, primary prevention by appropriate dosing of hydroxychloroquine offers the best chance of minimizing the risk of HCR.Keywords
This publication has 6 references indexed in Scilit:
- Adherence to Hydroxychloroquine Dosing Guidelines by RheumatologistsOphthalmology, 2017
- The Prevalence of Hydroxychloroquine Retinopathy and Toxic Dosing, and the Role of the Ophthalmologist in Reducing BothAmerican Journal of Ophthalmology, 2016
- Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)Ophthalmology, 2016
- The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine TherapyJAMA Ophthalmology, 2014
- The impact of different algorithms for ideal body weight on screening for hydroxychloroquine retinopathy in womenClinical Ophthalmology, 2014